Navigation Links
SkilaMederi Names Ray Joske as Chief Commercial Officer
Date:1/31/2013

MORRIS PLAINS, N.J., Jan. 31, 2013 /PRNewswire/ -- Global life sciences strategic advisory and data analytics solutions provider SkilaMederi today announced the appointment of Raymond Joske to its Executive Management Team as Chief Commercial Officer. In this role, Joske will oversee commercial efforts worldwide for SkilaMederi and report directly to CEO Kilian Weiss .

Mr. Joske has more than 28 years of executive experience in the client and support sides of the life sciences industry, including sales, sales management, marketing, new product development, disease management, analytics and market access. At Bristol-Myers Squibb, he held commercial roles in sales management, product marketing and market access. Mr. Joske also served as Senior Vice President of Marketing, Business Development and International Sales and Marketing for a Merck KGaA affiliate, and Senior Vice President of the Healthcare Analytics Group, a division of Gallagher Benefit Services. Before joining SkilaMederi, Mr. Joske oversaw new product development and marketing for MediMedia® Health, a provider of multichannel promotional health care-related campaigns.

"Ray offers the breadth of business development and marketing experience that will advance SkilaMederi's position as a unique life sciences advisory firm that harnesses expert counsel, big data analytics and other knowledge tools to deliver the predictive insight our clients need to achieve a competitive advantage," said SkilaMederi CEO Kilian Weiss . "We look forward to his contribution as SkilaMederi embarks on this next stage of growth."

For more information on SkilaMederi, please visit www.skilamederi.com.

About SkilaMederi
SkilaMederi is a specialized life sciences advisory firm that leverages big data and social network analytics to produce the predictive insight pharmaceutical and bioscience clients need to successfully position, launch and market new products. With deep life sciences industry expertise anchoring comprehensive service offerings, SkilaMederi provides strategic insight, social network analytics and knowledge-based tools distinct from conventional consultancies that offer only a few localized specialists or off-the-shelf software. SkilaMederi's tailored portfolio of strategic and analytics services draws upon its globally-networked subject matter experts and incisive "human crowd-sourced intelligence" data-gathering methods. The strength of those combined assets explains why the world's leading life science organizations turn to SkilaMederi to develop the most productive solutions for the most difficult challenges.

SkilaMederi has offices in the United States, Germany, the United Kingdom, France, and Ukraine.


'/>"/>
SOURCE SkilaMederi
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics names Ann Tobin as Chief Compliance Officer
2. Innovation Names Dr. Phil Samples Vice President, Government & Professional Services
3. Compressus Names Joe Lavelle as COO
4. Sophono Names Global Sales and Marketing Vice President
5. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
6. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
7. Alimera Sciences Names European Management Team
8. 2012 Facility of the Year Awards Program Names Mercks Vaccine Bulk Manufacturing Facility (VBF) Program of Projects as Overall Winner
9. Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors
10. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
11. Beckers Hospital Review Names 100 Hospitals With Great Womens Health Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... -- The Cincinnati location of Diplomat ... DPLO), has been awarded a Top Workplaces 2017 ... are based on an employee survey administered by WorkplaceDynamics, LLC, ... The survey measures several aspects of workplace culture, including alignment, ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... June 26, 2017 , ... If the devil is in ... red these days. According to recent estimates, 75 – 80% of the medical ... Some studies point to Electronic Health Records (EHR) with automated features designed to ...
(Date:6/25/2017)... CA (PRWEB) , ... June 24, 2017 , ... Create a feel-good lyric music video ... above footage and sound in the timeline and write in the lyrics to any song. ... flying back out. Each line of the text can be added modularly for optimal control. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... With a heatwave currently bearing down on Northern ... out at the pool. Being swimsuit ready is easy with laser hair removal. , ... again can be a burdensome routine when all you want to do is get out, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. ... 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine ... visits to the dentist fit into their patients’ busy lifestyles. Dental365 also gladly ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation ... significant harm to people with all chronic conditions, including mental illnesses, while increasing ... place the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it ...
Breaking Medicine News(10 mins):